Literature DB >> 11506853

Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome.

A P Cheung1.   

Abstract

OBJECTIVE: To assess the role of endometrial thickness on vaginal ultrasound assessment and menstrual history in predicting endometrial hyperplasia in women with polycystic ovary syndrome (PCOS) who presented with infertility due to anovulation.
METHODS: This was a prospective study in a university referral-based fertility and endocrine clinic. Fifty-six women with PCOS presenting with infertility due to anovulation underwent both vaginal ultrasound assessments and endometrial biopsies. The main outcome measures were the predictive value of sonographic endometrial thickness (primary objective) and the menstrual history with other clinical characteristics (secondary objective) for proliferative endometrium and endometrial hyperplasia in logistic regression analysis. Their predictive value was further examined by receiver operating characteristic curve analysis.
RESULTS: Thirty-six PCOS patients (64.3%) had proliferative endometrium and 20 (35.7%) had endometrial hyperplasia. Five of the latter (25%) had cytologic atypia. Endometrial thickness less than 7 mm or intermenstrual interval less than 3 months (corresponding to more than four menstrual periods yearly) was associated with proliferative endometrium only. The endometrial thickness correlated positively with endometrial hyperplasia (P =.018) and, together with the average intermenstrual interval, were significant predictors of endometrial hyperplasia (P <.001).
CONCLUSION: These findings point to the usefulness of obtaining a detailed menstrual history in women with PCOS by identifying those at increased risk of endometrial hyperplasia and who require an endometrial biopsy. The endometrial thickness corroborates this clinical impression and is particularly useful when the menstrual history is uncertain. Endometrial hyperplasia in this population is effectively excluded when the endometrial thickness is less than 7 mm.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506853     DOI: 10.1016/s0029-7844(01)01432-6

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  16 in total

Review 1.  Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women.

Authors:  Jing Zhang; Liulin Tang; Linglingli Kong; Taixiang Wu; Liangzhi Xu; Xin Pan; Guan J Liu
Journal:  Cochrane Database Syst Rev       Date:  2019-07-31

2.  Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome.

Authors:  A Villavicencio; A Goyeneche; C Telleria; K Bacallao; F Gabler; A Fuentes; M Vega
Journal:  Gynecol Oncol       Date:  2009-07-23       Impact factor: 5.482

3.  Long term health consequences of polycystic ovarian syndrome: a review analysis.

Authors:  A Daniilidis; K Dinas
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

4.  Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.

Authors:  D H Abbott; B H Rayome; D A Dumesic; K C Lewis; A K Edwards; K Wallen; M E Wilson; S E Appt; J E Levine
Journal:  Hum Reprod       Date:  2017-04-01       Impact factor: 6.918

Review 5.  Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women.

Authors:  Jing Zhang; Liulin Tang; Linglingli Kong; Taixiang Wu; Liangzhi Xu; Xin Pan; Guan J Liu
Journal:  Cochrane Database Syst Rev       Date:  2021-11-04

6.  Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome.

Authors:  Abha Majumdar; Tejshree A Singh
Journal:  J Hum Reprod Sci       Date:  2009-01

Review 7.  Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Authors:  Peter M Haddad; Angelika Wieck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Ultrasonographic endometrial thickness measurement is predictive for treatment response in simple endometrial hyperplasia without atypia.

Authors:  Enis Ozkaya; Vakkas Korkmaz; Yeşim Ozkaya; Alptekin Tosun; Tuncay Küçükozkan; Hüsne Bostan
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-03-01

9.  Endometrial histology and predictable clinical factors for endometrial disease in women with polycystic ovary syndrome.

Authors:  Joon Cheol Park; Su Yeon Lim; Tae Kyu Jang; Jin Gon Bae; Jong In Kim; Jeong Ho Rhee
Journal:  Clin Exp Reprod Med       Date:  2011-03-31

10.  Diagnosis and management of polycystic ovary syndrome in the UK (2004-2014): a retrospective cohort study.

Authors:  Tao Ding; Gianluca Baio; Paul J Hardiman; Irene Petersen; Cormac Sammon
Journal:  BMJ Open       Date:  2016-07-11       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.